Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

a Missouri jury awarded $495 Million to the family of a child who developed NEC from formula made by Abbott Laboratories. The baby suffered neurological damage and will require lifelong care. Call ...

If you're looking for a less overheated, more diversified and low-key group of blue-chip stocks than the usual "Magnificent Seven" mega-cap tech names, consider the Dividend Kings. [ Sign up for ...

However, investing in Dividend Kings isn't a guaranteed formula for market-beating ... regulatory changes and economic downturns. Abbott Laboratories fits this profile as a Dividend King, and ...

Abbott (ABT) ended the recent trading session at $135.87, demonstrating a -0.07% swing from the preceding day's closing price. This change was narrower than the S&P 500's 1.59% loss on the day.

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...